Custom Manufacturing Industry podcast is an entrepreneurship and motivational podcast on all platforms, hosted by Aaron Clippinger. Being CEO of multiple companies including the signage industry and the software industry, Aaron has over 20 years of consulting and business management. His software has grown internationally and with over a billion dollars annually going through the software. Using his Accounting degree, Aaron will be talking about his organizational ways to get things done. Hi ...
…
continue reading
コンテンツは Literal Humans によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Literal Humans またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。
Player FM -ポッドキャストアプリ
Player FMアプリでオフラインにしPlayer FMう!
Player FMアプリでオフラインにしPlayer FMう!
S3 Ep58: Reshaping Biosecurity with Kevin Flyangolts, Founder & CEO of Aclid
Manage episode 435518964 series 3301410
コンテンツは Literal Humans によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Literal Humans またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。
In this week’s episode of Tech Can’t Save Us, hosts Paul David and Maya Dharampal-Hornby are joined by Kevin Flyangolts, Founder & CEO of Aclid.
With biotechnology becoming increasingly digital and automated, biosecurity guidelines are constantly changing. Aclid enables end-to-end compliance for gene synthesis providers by automating biosecurity screenings, promoting education in the life science sector, and building trust between companies and customers.
Tune into this episode now to hear Kevin discuss how biosecurity concerns have evolved since covid-19, and explain why adaptive regulations, responsible practices, and automated screenings and verifications are the future of biosecurity.
Find more about Aclid here: https://www.aclid.bio/
Get in touch with Kevin here: https://www.linkedin.com/in/kevfly/
With biotechnology becoming increasingly digital and automated, biosecurity guidelines are constantly changing. Aclid enables end-to-end compliance for gene synthesis providers by automating biosecurity screenings, promoting education in the life science sector, and building trust between companies and customers.
Tune into this episode now to hear Kevin discuss how biosecurity concerns have evolved since covid-19, and explain why adaptive regulations, responsible practices, and automated screenings and verifications are the future of biosecurity.
Find more about Aclid here: https://www.aclid.bio/
Get in touch with Kevin here: https://www.linkedin.com/in/kevfly/
135 つのエピソード
Manage episode 435518964 series 3301410
コンテンツは Literal Humans によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Literal Humans またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。
In this week’s episode of Tech Can’t Save Us, hosts Paul David and Maya Dharampal-Hornby are joined by Kevin Flyangolts, Founder & CEO of Aclid.
With biotechnology becoming increasingly digital and automated, biosecurity guidelines are constantly changing. Aclid enables end-to-end compliance for gene synthesis providers by automating biosecurity screenings, promoting education in the life science sector, and building trust between companies and customers.
Tune into this episode now to hear Kevin discuss how biosecurity concerns have evolved since covid-19, and explain why adaptive regulations, responsible practices, and automated screenings and verifications are the future of biosecurity.
Find more about Aclid here: https://www.aclid.bio/
Get in touch with Kevin here: https://www.linkedin.com/in/kevfly/
With biotechnology becoming increasingly digital and automated, biosecurity guidelines are constantly changing. Aclid enables end-to-end compliance for gene synthesis providers by automating biosecurity screenings, promoting education in the life science sector, and building trust between companies and customers.
Tune into this episode now to hear Kevin discuss how biosecurity concerns have evolved since covid-19, and explain why adaptive regulations, responsible practices, and automated screenings and verifications are the future of biosecurity.
Find more about Aclid here: https://www.aclid.bio/
Get in touch with Kevin here: https://www.linkedin.com/in/kevfly/
135 つのエピソード
所有剧集
×プレーヤーFMへようこそ!
Player FMは今からすぐに楽しめるために高品質のポッドキャストをウェブでスキャンしています。 これは最高のポッドキャストアプリで、Android、iPhone、そしてWebで動作します。 全ての端末で購読を同期するためにサインアップしてください。